Journal Article

Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes

Wanner, Christoph, Molitch, Mark E., Mogensen, Carl E., Flyvbjerg, Allan, Adler, Amanda I., Nelson, Robert G., So, Wing-Yee, Wheeler, David C., de Zeeuw, Dick, Kasiske, Bertram L.

2015

Overview

The incidence and prevalence of diabetes mellitus (DM) continue to grow markedly throughout the world, due primarily to the increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced the proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), the sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in the management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of the renin–angiotensin–aldosterone system; and lipid management.

• Publisher: Elsevier Inc,Elsevier Limited
• Subject: albuminuria / Albuminuria - etiology / blood pressure / diabetic kidney disease / Diabetic Nephropathies - complications / Diabetic Nephropathies - diagnosis / Diabetic Nephropathies - therapy / Disease Progression / glycemic control / Humans / Hyperglycemia - etiology / Hypertension - etiology / lipid management